Nabriva Therapeutics plc Liabilities, Noncurrent
Nabriva Therapeutics plc had Liabilities, Noncurrent of $696.00 thousand as of 2023-06-30, per its 10-Q filed 2023-10-19.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LiabilitiesNoncurrent · last filed 2023-10-19
- 2023-06-30: Liabilities, Noncurrent $696.00K.
- 2023-03-31: Liabilities, Noncurrent $697.00K.
- 2022-12-31: Liabilities, Noncurrent $867.00K.
- 2022-09-30: Liabilities, Noncurrent $977.00K.
| Period end | Liabilities, Noncurrent |
|---|---|
| 2023-06-30 | $696.00K 10-Q · filed 2023-10-19 |
| 2023-03-31 | $697.00K 10-Q · filed 2023-05-22 |
| 2022-12-31 | $867.00K 10-Q · filed 2023-10-19 |
| 2022-09-30 | $977.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $956.00K 10-Q · filed 2022-08-03 |
| 2022-03-31 | $4.88M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $5.22M 10-K · filed 2023-04-17 |
| 2021-09-30 | $6.11M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $7.00M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $6.12M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $6.78M 10-K · filed 2022-03-29 |
| 2020-09-30 | $9.57M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $9.59M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $9.13M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $36.20M 10-K · filed 2021-03-11 |
| 2019-09-30 | $36.02M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $26.12M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $25.79M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $23.98M 10-K · filed 2020-03-12 |
| 2018-09-30 | $954.00K 10-Q · filed 2018-11-06 |
| 2018-06-30 | $828.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $636.00K 10-Q · filed 2018-05-08 |
| 2017-12-31 | $435.00K 10-K · filed 2019-03-12 |
| 2017-09-30 | $425.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $364.00K 10-Q · filed 2017-08-07 |
| 2017-03-31 | $337.00K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $107.00K 10-K · filed 2018-03-16 |